Emerging Biotechs
Companies with 1-10 approved drugs showing momentum: recent approvals, priority reviews, and active pipelines Updated: 3/5/2026
100
Emerging Biotechs
1-10 approved drugs
78
Phase 3 Trials
Near approval
90
With Priority Review
FDA fast-tracked
48
Avg Score
Momentum indicator
Scoring Methodology
Companies scored based on: Recent Approvals (3yr) × 20 + Priority Reviews × 10 + Phase 3 Trials × 5 + Phase 2 Trials × 2. Higher scores indicate momentum.
| Company | Approved | Ph3 | Ph2 | Priority | Score | Top Drugs |
|---|---|---|---|---|---|---|
| Regeneron 2 recent | 8 | 76 | 102 | 7 | 694 | |
| Vertex Pharmaceuticals 2 recent | 7 | 0 | 0 | 7 | 110 | |
| ACCORD BIOPHARMA INC. 5 recent | 5 | 0 | 0 | 0 | 100 | |
| INCYTE CORP 2 recent | 5 | 0 | 0 | 5 | 90 | |
| IPSEN 2 recent | 4 | 0 | 0 | 4 | 80 | |
| LEADIANT BIOSCI INC | 7 | 0 | 0 | 7 | 70 | |
| GLAUKOS 2 recent | 5 | 0 | 0 | 3 | 70 | |
| DAIICHI SANKYO INC 2 recent | 4 | 0 | 0 | 3 | 70 | |
| AUCTA 3 recent | 7 | 0 | 0 | 0 | 60 | |
| VANDA PHARMS INC 2 recent | 6 | 0 | 0 | 2 | 60 | |
| NEUROCRINE 2 recent | 3 | 0 | 0 | 2 | 60 | |
| SPRINGWORKS 2 recent | 2 | 0 | 0 | 2 | 60 | |
| BTG INTL 1 recent | 5 | 0 | 0 | 4 | 60 | |
| SHANGHAI HENLIUS BIOTECH 3 recent | 3 | 0 | 0 | 0 | 60 | |
| ENTASIS THERAP 2 recent | 2 | 0 | 0 | 2 | 60 | |
| XANODYNE PHARM | 9 | 0 | 0 | 5 | 50 | |
| CUBIST PHARMS LLC | 5 | 0 | 0 | 5 | 50 | |
| CMP DEV LLC 2 recent | 7 | 0 | 0 | 1 | 50 | |
| OTSUKA 1 recent | 10 | 0 | 0 | 3 | 50 | |
| AMICUS THERAP US 2 recent | 3 | 0 | 0 | 1 | 50 | |
| SENTYNL THERAPS INC 1 recent | 4 | 0 | 0 | 3 | 50 | |
| PURDUE PHARMA LP 1 recent | 9 | 0 | 0 | 3 | 50 | |
| MIRUM 1 recent | 3 | 0 | 0 | 3 | 50 | |
| CARWIN PHARM ASSOC 2 recent | 2 | 0 | 0 | 1 | 50 | |
| INDIVIOR 1 recent | 6 | 0 | 0 | 3 | 50 | |
| CHIESI FARMACEUTICI SPA 1 recent | 3 | 0 | 0 | 3 | 50 | |
| IONIS PHARMS INC 2 recent | 2 | 0 | 0 | 1 | 50 | |
| INTL MEDICATION SYS 1 recent | 10 | 0 | 0 | 2 | 40 | |
| KINDOS 1 recent | 6 | 0 | 0 | 2 | 40 | |
| ZENARA 2 recent | 5 | 0 | 0 | 0 | 40 | |
| STERISCIENCE 2 recent | 9 | 0 | 0 | 0 | 40 | |
| HAINAN POLY 1 recent | 10 | 0 | 0 | 2 | 40 | |
| VALIDUS PHARMS | 10 | 0 | 0 | 4 | 40 | |
| MILLA PHARMS 1 recent | 9 | 0 | 0 | 2 | 40 | |
| ACTELION 1 recent | 7 | 0 | 0 | 2 | 40 | |
| MSN PHARMACEUTICALS INC 2 recent | 3 | 0 | 0 | 0 | 40 | |
| DECIPHERA PHARMS 1 recent | 2 | 0 | 0 | 2 | 40 | |
| ROSEMONT PHARMS 2 recent | 2 | 0 | 0 | 0 | 40 | |
| ACADIA PHARMS INC 1 recent | 3 | 0 | 0 | 2 | 40 | |
| ALNYLAM PHARMS INC | 4 | 0 | 0 | 4 | 40 | |
| KALEO INC | 4 | 0 | 0 | 4 | 40 | |
| SCIENTURE 2 recent | 2 | 0 | 0 | 0 | 40 | |
| JAZZ PHARMS 1 recent | 4 | 0 | 0 | 2 | 40 | |
| CEPHALON | 6 | 0 | 0 | 4 | 40 | |
| BIOMARIN PHARM | 5 | 0 | 0 | 4 | 40 | |
| PHATHOM 1 recent | 3 | 0 | 0 | 2 | 40 | |
| ALEXION PHARM | 4 | 0 | 0 | 4 | 40 | |
| ACROTECH BIOPHARMA 1 recent | 6 | 0 | 0 | 2 | 40 | |
| BIO-THERA SOLUTIONS LTD 2 recent | 2 | 0 | 0 | 0 | 40 | |
| CATALYST PHARMS 1 recent | 3 | 0 | 0 | 2 | 40 | |
| INSMED INC 1 recent | 2 | 0 | 0 | 2 | 40 | |
| SERVIER 1 recent | 2 | 0 | 0 | 2 | 40 | |
| FORMYCON AG 2 recent | 2 | 0 | 0 | 0 | 40 | |
| SOFIE | 3 | 2 | 2 | 2 | 34 | |
| LOTUS PHARM CO LTD 1 recent | 6 | 0 | 0 | 1 | 30 | |
| UCSF RODIOPHARM | 4 | 0 | 0 | 3 | 30 | |
| UNIV TX MD ANDERSON | 4 | 0 | 0 | 3 | 30 | |
| CARDINAL HEALTH 414 | 5 | 0 | 0 | 3 | 30 | |
| MCPRF | 4 | 0 | 0 | 3 | 30 | |
| ENDO PHARMS | 7 | 0 | 0 | 3 | 30 | |
| US ARMY | 5 | 0 | 0 | 3 | 30 | |
| ALMAJECT 1 recent | 5 | 0 | 0 | 1 | 30 | |
| SAREPTA THERAPS INC | 3 | 0 | 0 | 3 | 30 | |
| USWM 1 recent | 4 | 0 | 0 | 1 | 30 | |
| EMD SERONO INC | 8 | 0 | 0 | 3 | 30 | |
| AXSOME 1 recent | 2 | 0 | 0 | 1 | 30 | |
| AGEPHA PHARMA FZ 1 recent | 1 | 0 | 0 | 1 | 30 | |
| UNITED THERAP | 5 | 0 | 0 | 3 | 30 | |
| AKARX INC 1 recent | 2 | 0 | 0 | 1 | 30 | |
| PHARMACIA | 6 | 0 | 0 | 3 | 30 | |
| ZEVRA DENMARK 1 recent | 1 | 0 | 0 | 1 | 30 | |
| UROGEN PHARMA 1 recent | 2 | 0 | 0 | 1 | 30 | |
| LEO PHARMA AS 1 recent | 9 | 0 | 0 | 1 | 30 | |
| ASCENDIS PHARMA BONE 1 recent | 1 | 0 | 0 | 1 | 30 | |
| DAY ONE BIOPHARMS 1 recent | 1 | 0 | 0 | 1 | 30 | |
| CHIMERIX 1 recent | 1 | 0 | 0 | 1 | 30 | |
| ARGENX BV 1 recent | 2 | 0 | 0 | 1 | 30 | |
| BLUE EARTH 1 recent | 2 | 0 | 0 | 1 | 30 | |
| ITALFARMACO SPA 1 recent | 1 | 0 | 0 | 1 | 30 | |
| GENMAB US, INC. 1 recent | 1 | 0 | 0 | 1 | 30 | |
| CHIRHOCLIN | 3 | 0 | 0 | 3 | 30 | |
| TAIHO ONCOLOGY | 3 | 0 | 0 | 3 | 30 | |
| PTC THERAP 1 recent | 2 | 0 | 0 | 1 | 30 | |
| GUERBET | 6 | 0 | 0 | 3 | 30 | |
| MDD US 1 recent | 3 | 0 | 0 | 1 | 30 | |
| ARS PHARMS OPERATION 1 recent | 1 | 0 | 0 | 1 | 30 | |
| STEALTH BIOTHERAPS 1 recent | 1 | 0 | 0 | 1 | 30 | |
| NOVA LABS LTD 1 recent | 2 | 0 | 0 | 1 | 30 | |
| SOLENO THERAP 1 recent | 1 | 0 | 0 | 1 | 30 | |
| DIZAL JIANGSU 1 recent | 1 | 0 | 0 | 1 | 30 | |
| LUMICELL 1 recent | 1 | 0 | 0 | 1 | 30 | |
| NUVATION 1 recent | 1 | 0 | 0 | 1 | 30 | |
| MERUS N.V. 1 recent | 1 | 0 | 0 | 1 | 30 | |
| OTSUKA PHARM CO LTD 1 recent | 2 | 0 | 0 | 1 | 30 | |
| MADRIGAL 1 recent | 1 | 0 | 0 | 1 | 30 | |
| BRAEBURN 1 recent | 1 | 0 | 0 | 1 | 30 | |
| CORMEDIX 1 recent | 1 | 0 | 0 | 1 | 30 | |
| ISTX 1 recent | 1 | 0 | 0 | 1 | 30 | |
| VERASTEM INC 1 recent | 1 | 0 | 0 | 1 | 30 | |
| OMEROS CORP 1 recent | 1 | 0 | 0 | 1 | 30 |
Why these companies? Emerging biotechs (1-10 approved drugs) with recent FDA approvals, priority reviews, or active late-stage pipelines represent potential acquisition targets or partnership opportunities.